Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9237487rdf:typepubmed:Citationlld:pubmed
pubmed-article:9237487lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9237487lifeskim:mentionsumls-concept:C0497327lld:lifeskim
pubmed-article:9237487lifeskim:mentionsumls-concept:C0020258lld:lifeskim
pubmed-article:9237487lifeskim:mentionsumls-concept:C0003595lld:lifeskim
pubmed-article:9237487lifeskim:mentionsumls-concept:C0299212lld:lifeskim
pubmed-article:9237487lifeskim:mentionsumls-concept:C1314792lld:lifeskim
pubmed-article:9237487lifeskim:mentionsumls-concept:C0678951lld:lifeskim
pubmed-article:9237487lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:9237487pubmed:issue3lld:pubmed
pubmed-article:9237487pubmed:dateCreated1997-9-24lld:pubmed
pubmed-article:9237487pubmed:abstractTextNormal pressure hydrocephalus (NPH) is characterized by dementia, gait disorders and urinary incontinence. Apolipoprotein E (ApoE) epsilon4 allele has been associated with severity of dementia in Alzheimer's disease (AD) and in other forms of dementia. Moreover, homozygosity of the A allele of the alpha1-antichymotrypsin (ACT) gene and of allele 1 of the presenilin-1 (PS-1) gene was associated with an increased risk for late onset AD. We analyzed the distribution of ApoE, ACT and PS-1 genotypes and the corresponding allele frequencies in 13 NPH patients. No differences were found in ACT and PS-1 polymorphism distributions in the patients studied with respect to the control group. An increased ApoE epsilon4 allele frequency was observed in NPH patients with respect to controls, thus suggesting that epsilon4 allele may also be involved in the pathogenesis of the disease.lld:pubmed
pubmed-article:9237487pubmed:languageenglld:pubmed
pubmed-article:9237487pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9237487pubmed:citationSubsetIMlld:pubmed
pubmed-article:9237487pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9237487pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9237487pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9237487pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9237487pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9237487pubmed:statusMEDLINElld:pubmed
pubmed-article:9237487pubmed:monthJullld:pubmed
pubmed-article:9237487pubmed:issn0304-3940lld:pubmed
pubmed-article:9237487pubmed:authorpubmed-author:AmaducciLLlld:pubmed
pubmed-article:9237487pubmed:authorpubmed-author:SorbiSSlld:pubmed
pubmed-article:9237487pubmed:authorpubmed-author:SerioAAlld:pubmed
pubmed-article:9237487pubmed:authorpubmed-author:TeddeAAlld:pubmed
pubmed-article:9237487pubmed:authorpubmed-author:PetruzziCClld:pubmed
pubmed-article:9237487pubmed:authorpubmed-author:GuarnieriB...lld:pubmed
pubmed-article:9237487pubmed:authorpubmed-author:NacmiasBBlld:pubmed
pubmed-article:9237487pubmed:authorpubmed-author:OrtenziLLlld:pubmed
pubmed-article:9237487pubmed:issnTypePrintlld:pubmed
pubmed-article:9237487pubmed:day4lld:pubmed
pubmed-article:9237487pubmed:volume229lld:pubmed
pubmed-article:9237487pubmed:ownerNLMlld:pubmed
pubmed-article:9237487pubmed:authorsCompleteYlld:pubmed
pubmed-article:9237487pubmed:pagination177-80lld:pubmed
pubmed-article:9237487pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9237487pubmed:meshHeadingpubmed-meshheading:9237487-...lld:pubmed
pubmed-article:9237487pubmed:meshHeadingpubmed-meshheading:9237487-...lld:pubmed
pubmed-article:9237487pubmed:meshHeadingpubmed-meshheading:9237487-...lld:pubmed
pubmed-article:9237487pubmed:meshHeadingpubmed-meshheading:9237487-...lld:pubmed
pubmed-article:9237487pubmed:meshHeadingpubmed-meshheading:9237487-...lld:pubmed
pubmed-article:9237487pubmed:meshHeadingpubmed-meshheading:9237487-...lld:pubmed
pubmed-article:9237487pubmed:meshHeadingpubmed-meshheading:9237487-...lld:pubmed
pubmed-article:9237487pubmed:meshHeadingpubmed-meshheading:9237487-...lld:pubmed
pubmed-article:9237487pubmed:meshHeadingpubmed-meshheading:9237487-...lld:pubmed
pubmed-article:9237487pubmed:meshHeadingpubmed-meshheading:9237487-...lld:pubmed
pubmed-article:9237487pubmed:meshHeadingpubmed-meshheading:9237487-...lld:pubmed
pubmed-article:9237487pubmed:meshHeadingpubmed-meshheading:9237487-...lld:pubmed
pubmed-article:9237487pubmed:meshHeadingpubmed-meshheading:9237487-...lld:pubmed
pubmed-article:9237487pubmed:meshHeadingpubmed-meshheading:9237487-...lld:pubmed
pubmed-article:9237487pubmed:meshHeadingpubmed-meshheading:9237487-...lld:pubmed
pubmed-article:9237487pubmed:meshHeadingpubmed-meshheading:9237487-...lld:pubmed
pubmed-article:9237487pubmed:meshHeadingpubmed-meshheading:9237487-...lld:pubmed
pubmed-article:9237487pubmed:year1997lld:pubmed
pubmed-article:9237487pubmed:articleTitleAnalysis of apolipoprotein E, alpha1-antichymotrypsin and presenilin-1 genes polymorphisms in dementia caused by normal pressure hydrocephalus in man.lld:pubmed
pubmed-article:9237487pubmed:affiliationDepartment of Neurological and Psychiatric Sciences, University of Florence, Italy.lld:pubmed
pubmed-article:9237487pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9237487pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9237487lld:pubmed